BioDelivery Sciences International, Inc.
BioDelivery Sciences Announces Issuance of U.S. Patent Extending Exclusivity for the BEMA Delivery Technology
Published in Lab Business Week, September 13th, 2009
"The United States Patent Office's issuance of this patent provides BDSI longer and more extensive protection for both ONSOLIS and the BEMA platform technology," stated Charles Dadswell, General Counsel for BDSI. "The U.S. Patent Office has acknowledged and extended the expiration date of the patent by 835 days. However, BDSI believes it is entitled to, and will request, a further extension of this period that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2009-09-13)
More Articles from Lab Business Week
- A. James Clark School of Engineering
Mark J. Lewis to Lead Clark School's Highly Ranked Aerospace Engineering Department - Angiology
IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent - Biovail Corporation
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera - Cholestasis Therapy
Study data from Eisai Co., Ltd. update knowledge of cholestasis therapy - Chronic Obstructive Pulmonary Disease
Four Studies Published in the Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations - Colitis
Research from Ajinomoto Co., Inc. provides new data on colitis - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
